Neven Baršić

Non-alcoholic fatty liver disease – A global public health perspective

Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis

Epidemiology and natural history of non-alcoholic fatty liver disease

Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function

Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Intestinal permeability – a new target for disease prevention and therapy

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

Serum cytokeratin‐18 in the diagnosis of non‐alcoholic steatohepatitis: A meta‐analysis

Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets

Overview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease

Therapy of nonalcoholic fatty liver disease: current status.